Press release
Implantable Cardioverter Defibrillators (ICDs) Market Outlook 2025-2034: Key Trends, Growth Drivers, and Market Share
Implantable Cardioverter Defibrillators ICDs
The rise in cardiovascular diseases (CVDs) is predicted to fuel the expansion of the implantable cardioverter defibrillators (ICDs) market in the future. CVDs encompass a variety of ailments that impact the heart and blood vessels, including heart attacks, strokes, and hypertension, often triggered by unhealthy eating habits, physical inactivity, smoking, and hereditary factors. The escalating incidence of cardiovascular diseases is mainly attributed to aging populations, unhealthy lifestyle habits, and increasing rates of risk elements such as obesity, diabetes, and hypertension. Implantable cardioverter defibrillators (ICDs) aid in the control of CVDs by delivering life-saving electric shocks to reinstate normal heart rhythms in patients susceptible to unexpected cardiac arrest. For example, as per the Australian Institute of Health and Welfare, an Australian government agency, certified deaths caused by coronary heart disease (CHD) escalated to 14,100 in 2021 and increased further to 14,900 in 2022. Consequently, the escalating incidence of cardiovascular diseases (CVDs) is spurring the expansion of the implantable cardioverter defibrillators (ICDs) market.
Get Your Implantable Cardioverter Defibrillators (ICDs) Market Report Here:
https://www.thebusinessresearchcompany.com/report/implantable-cardioverter-defibrillators-icds-global-market-report
What Is the projected market size and growth rate for the implantable cardioverter defibrillators (icds) market?
The market size of implantable cardioverter defibrillators (ICDs) has shown impressive growth in the past few years. It is projected to rise from $3.76 billion in 2024 to $3.99 billion in 2025, showcasing a compound annual growth rate (CAGR) of 6.0%. This tremendous growth during the historic period can be credited to a rise in cases of sudden cardiac arrest, recognition of implantable cardioverter defibrillator for preventional use against sudden cardiac arrest, increased awareness amongst the public, a surge in the elderly population, encouragement from governments and healthcare institutions, and enhanced access to healthcare.
Projected substantial growth is anticipated in the size of the implantable cardioverter defibrillators (ICDs) market in the forthcoming years. The market is expected to escalate to a worth of $4.99 billion by 2029, expanding at a compound annual growth rate (CAGR) of 5.8%. Factors contributing to this growth during the forecasted period include rising adoption of implantable defibrillators, a surge in the need for more personalized cardiac care, an increased incidence of cardiac rhythm disorders, and growing demand in budding markets. Emerging trends for the projected period encompass technological innovations, the launch of subcutaneous ICD that circumvent transvenous leads, a surge in demand for hybrid ICD devices with pacemaker characteristics, improvements in sensing and detection algorithms, ongoing progress in wireless charging and battery technology, and incorporation of artificial intelligence (AI) in healthcare and data analytics.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20839&type=smp
How are the latest trends influencing the growth of the implantable cardioverter defibrillators (icds) market?
Leading firms in the implantable cardioverter defibrillators (ICDs) market are concentrating their efforts on technological breakthroughs, including low current consumption defibrillators, to elevate the efficiency of their devices, prolong battery lifespans, and better patient comfort levels. Defibrillators consuming less current are engineered to dispatch electrical shocks to the heart while using less power, thereby extending battery longevity and guaranteeing efficient arrhythmia treatment. For example, in Japan, MicroPort CRM, a medicinal devices producer based in France, introduced the ULYS implantable cardioverter defibrillator (ICD) and the INVICTA defibrillation lead in October 2023, indicating a major step forward in cardiac treatment technology. These products contain cutting-edge features, like low current consumption for extending battery lifespan and MRI-compatibility, ensuring they are appropriate for patients requiring imaging processes. The ULYS ICD incorporates the PARAD+ arrhythmia identification algorithm and AutoMRI feature, augmenting patient security in MRI examinations. Furthermore, the INVICTA lead accomplished a 100% successful implantation rate and a 97.4% rate free of complications during clinical trials, underlining its dependability and efficacy.
What major market segments define the scope and growth of the implantable cardioverter defibrillators (icds) market?
The implantable cardioverter defibrillators (ICDs) market covered in this report is segmented -
1) By Type: Single Chamber Implantable Cardioverter Defibrillators (ICDs), Dual Chamber Implantable Cardioverter Defibrillators (ICDs), Biventricular Devices
2) By Applications: Bradycardia, Tachycardia, Heart Failure, Other Applications
3) By End User: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Other End Users
Subsegments:
1) By Single Chamber Implantable Cardioverter Defibrillators (ICDs): Standard Single Chamber ICDs, MRI-Compatible Single Chamber ICDs, Wireless Single Chamber ICDs
2) By Dual Chamber Implantable Cardioverter Defibrillators (ICDs): Standard Dual Chamber ICDs, MRI-Compatible Dual Chamber ICDs, Wireless Dual Chamber ICDs
3) By Biventricular Devices: CRT-D (Cardiac Resynchronization Therapy Defibrillator), CRT-P (Cardiac Resynchronization Therapy Pacemaker), Biventricular ICDs With Advanced Features (Remote Monitoring, Wireless Capabilities)
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20839
Which region dominates the implantable cardioverter defibrillators (icds) market?
North America was the largest region in the implantable cardioverter defibrillators market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the implantable cardioverter defibrillators (ICDs) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Which key market leaders are driving the implantable cardioverter defibrillators (icds) industry growth?
Major companies operating in the implantable cardioverter defibrillators (ICDs) market are Abbott Laboratories, Medtronic Inc., Koninklijke Philips N.V., Boston Scientific Corporation, ZOLL Medical Corporation, St. Jude Medical Inc., BIOTRONIK SE & Co. KG, Nihon Kohden Corporation, Fukuda Denshi Co. Ltd., LivaNova PLC, MicroPort Scientific Corporation, Japan Lifeline Co. Ltd., AtriCure Inc., Physio-Control Inc., BPL Medical Technologies Private Limited, Kestra Medical Technologies Inc., CU Medical Germany GmbH, Metrax GmbH, Intermedics Inc., Sorin Group S.p.A.
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=20839&type=smp
What Is Covered In The Implantable Cardioverter Defibrillators (ICDs) Global Market Report?
•Market Size Forecast: Examine the implantable cardioverter defibrillators (icds) market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the implantable cardioverter defibrillators (icds) market for a structured understanding.
•Key Players Overview: Analyze major players in the implantable cardioverter defibrillators (icds) market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the implantable cardioverter defibrillators (icds) market.
•Segment Contributions: Evaluate how different segments drive overall growth in the implantable cardioverter defibrillators (icds) market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the implantable cardioverter defibrillators (icds) market.
•Industry Challenges: Identify potential risks and obstacles affecting the implantable cardioverter defibrillators (icds) market.
•Competitive Landscape: Review strategic developments in the implantable cardioverter defibrillators (icds) market, including expansions, agreements, and new product launches.
Learn More About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Implantable Cardioverter Defibrillators (ICDs) Market Outlook 2025-2034: Key Trends, Growth Drivers, and Market Share here
News-ID: 3944397 • Views: …
More Releases from The Business Research Company
Percutaneous Puncture Surgery Robot Market Analysis Highlights Growth To $3.54 B …
The market for percutaneous puncture surgery robots is on the verge of significant expansion, driven by rapid technological advances and increasing adoption in healthcare settings. As robotic systems become more sophisticated and integrated with cutting-edge technologies, this sector is set to transform minimally invasive surgical procedures. Below is a detailed exploration of the market's size, key players, trends, and segmentation that shape its future trajectory.
Projected Growth and Market Size of…
Pedicle Screw Systems Market Study Highlights How Industry Demand Is Evolving
The pedicle screw systems market is set to experience significant expansion in the coming years, driven by advancements in spinal surgery techniques and increasing patient demand. This market's evolution reflects growing medical needs and ongoing innovation, positioning it for substantial growth by 2030.
Forecasted Market Size and Growth Trajectory for Pedicle Screw Systems
The value of the pedicle screw systems market is projected to reach $7.65 billion by 2030, growing…
Pediatric Orthopedic Implants Market Research Reveals Strong 10.8% CAGR Outlook …
The pediatric orthopedic implants market is on track for significant expansion as advancements in technology and growing healthcare needs drive demand. Innovations in implant design and personalized treatment options are setting the stage for transformative growth in this specialized segment of medical devices. Below is a detailed overview of the current market size, key industry players, emerging trends, and segmentation that define this market's future.
Pediatric Orthopedic Implants Market Size and…
Pediatric Interventional Cardiology Market Intelligence Report Covers Trends, Se …
The pediatric interventional cardiology field is on track for significant expansion, driven by advances in medical technology and growing demand for specialized cardiac care for children. This sector is expected to see dynamic growth as innovative devices and techniques become more widely adopted to improve patient outcomes.
Projected Market Size and Growth Trajectory of the Pediatric Interventional Cardiology Market
The market for pediatric interventional cardiology is forecasted to grow steadily,…
More Releases for ICD
Riman launches ICD skincare line with seven products for sensitive skin
Image: https://www.globalnewslines.com/uploads/2026/06/1782454220.jpg
K-beauty brand Riman introduces its ICD line, featuring seven products including cleansing oil, powder wash, calming gel, multi stick balm, oil mist, booster-serum package, and cream, designed for sensitive skin.
Riman introduces ICD skincare line
K-beauty brand Riman has launched its ICD line of skincare products, featuring seven formulations designed for sensitive skin. The products include a moisture cleansing oil, cleansing powder wash, calming balance gel, multi stick balm, two-phase oil…
ICD Code Converter Now Available
Clearwater, FL- EON Systems, Inc., the provider of The Digital Office™, a complete software suite for healthcare providers, is excited to announce the launch of its ICD Converter App. The company’s new product, which launched on October 31st, 2014, is available on all Android®, iPad® and iPhone® products.
EON’s ICD Converter app features both ICD-9 to ICD-10 conversion and ICD-10 to ICD-9 conversion. In addition…
Career Step Releases Its New ICD-10 FastTrack Course
PROVO, Utah—September 20, 2013— Career Step, an online school offering career-focused education, is pleased to announce the release of its new ICD-10 FastTrack course, which is designed to prepare ICD-9 trained and experienced medical coders for the October 1, 2014 transition to the ICD-10 code set. This streamlined program was developed in collaboration with renowned industry experts Ann Zeisset, RHIT, CCS, CCS-P, and Gail Smith, MA, RHIA, CCS-P, as well…
Career Step Launches ICD-10-CM/ICD-10-PCS Code Set Training at HIMSS13
PROVO, Utah—March 4, 2013— Career Step, an online education company, is pleased to announce the launch of its ICD-10-CM and ICD-10-PCS code set training at the HIMSS13 Annual Conference & Exhibit. The courses are available through Career Step’s ICD-10 education offering, The ICD-10 Solution, developed in partnership with YES HIM Consulting, Inc., a firm specializing in ICD-10 preparation since 2009.
“As healthcare providers move through their ICD-10 transition plans, ICD-10 code…
Career Step and YES HIM Consulting, Inc. Launch The ICD-10 Solution
PROVO, Utah—Career Step, a leading online healthcare school, and YES HIM Consulting, Inc., a firm specializing in health information management and coding, have announced the launch of their joint ICD-10 training program, The ICD-10 Solution. The joint venture's education programs are now available and are designed to help organizations train their employees on the changes required by the mandated October 2013 transition to ICD-10 codes.
"The required conversion to ICD-10…
Avior Computnig Releases ICD-10 Knowledge Module
Avior Computing Corporation, a leader in automated risk and compliance management, announced today the immediate availability of an ICD-10 Knowledge Module for the firm’s BenchMark compliance management solutions.
The ICD-10 Knowledge Module provides all the content for the Avior BenchMark v6 platform, also released today, to streamline management of the complex interactions between health plans and healthcare providers and their trading partners.
Avior’s ICD-10 Knowledge Module is currently in production use…
